Evidence map›Paper›PMID 26589912›Full record

ArticleHaematologica2016

Mathematical modeling reveals differential effects of erythropoietin on proliferation and lineage commitment of human hematopoietic progenitors in early erythroid culture.

Daniel Ward, Deborah Carter, Martin Homer, Lucia Marucci, Alexandra Gampel

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Daniel WardDepartment of Engineering Mathematics, Faculty of Engineering, University of Bristol.
Deborah CarterSchool of Biochemistry, Faculty of Medical and Veterinary Science, University of Bristol, UK.
Martin HomerDepartment of Engineering Mathematics, Faculty of Engineering, University of Bristol.
Lucia MarucciDepartment of Engineering Mathematics, Faculty of Engineering, University of Bristol.
Alexandra GampelSchool of Biochemistry, Faculty of Medical and Veterinary Science, University of Bristol, UK a.gampel@bristol.ac.uk.
University of Bristol · GB

Funding

Department of Health RP-PG-0310-1004Department of Health RP-PG-0310-1004-AMT
6 · The paper itself

Abstract

Erythropoietin is essential for the production of mature erythroid cells, promoting both proliferation and survival. Whether erythropoietin and other cytokines can influence lineage commitment of hematopoietic stem and progenitor cells is of significant interest. To study lineage restriction of the common myeloid progenitor to the megakaryocyte/erythroid progenitor of peripheral blood CD34(+) cells, we have shown that the cell surface protein CD36 identifies the earliest lineage restricted megakaryocyte/erythroid progenitor. Using this marker and carboxyfluorescein succinimidyl ester to track cell divisions in vitro, we have developed a mathematical model that accurately predicts population dynamics of erythroid culture. Parameters derived from the modeling of cultures without added erythropoietin indicate that the rate of lineage restriction is not affected by erythropoietin. By contrast, megakaryocyte/erythroid progenitor proliferation is sensitive to erythropoietin from the time that CD36 first appears at the cell surface. These results shed new light on the role of erythropoietin in erythropoiesis and provide a powerful tool for further study of hematopoietic progenitor lineage restriction and erythropoiesis.

Indexed as

Models, StatisticalBiomarkersCD36 AntigensCell CycleCell DifferentiationCell LineageCell TrackingErythroid CellsErythropoiesisErythropoietinGene ExpressionHematopoietic Stem CellsHumansImmunophenotypingInsulin-Like Growth Factor IIntegrin beta3BiomarkersCD36 AntigensErythropoietinIL3 protein, humanInsulin-Like Growth Factor IIntegrin beta3Interleukin-3ITGB3 protein, humanStem Cell Factor

Identifiers

PMID26589912
PMCPMC4815720
OpenAlexW2175643471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.